Cargando…
Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease
BACKGROUND: The role of intestinal microbiota in inflammatory bowel diseases is intensively researched. Pediatric studies on the relation between microbiota and treatment response are sparse. We aimed to determine whether absolute abundances of gut microbes characterize the response to infliximab in...
Autores principales: | Höyhtyä, Miikka, Korpela, Katri, Saqib, Schahzad, Junkkari, Sofia, Nissilä, Eija, Nikkonen, Anne, Dikareva, Evgenia, Salonen, Anne, de Vos, Willem M, Kolho, Kaija-Leena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825283/ https://www.ncbi.nlm.nih.gov/pubmed/36040412 http://dx.doi.org/10.1093/ibd/izac182 |
Ejemplares similares
-
The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α
por: Ventin-Holmberg, Rebecka, et al.
Publicado: (2022) -
The Effect of Antibiotics on the Infant Gut Fungal Microbiota
por: Ventin-Holmberg, Rebecka, et al.
Publicado: (2022) -
Quantitative insights into effects of intrapartum antibiotics and birth mode on infant gut microbiota in relation to well-being during the first year of life
por: Jokela, Roosa, et al.
Publicado: (2022) -
Cohort profile: Finnish Health and Early Life Microbiota (HELMi) longitudinal birth cohort
por: Korpela, Katri, et al.
Publicado: (2019) -
Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
por: Wedenoja, Satu, et al.
Publicado: (2022)